ZBH vs. ESLOY: Which Stock Is the Better Value Option?

Core Insights - The article compares Zimmer Biomet (ZBH) and EssilorLuxottica Unsponsored ADR (ESLOY) to determine which stock presents a better value opportunity for investors [1] Valuation Metrics - ZBH has a forward P/E ratio of 12.07, while ESLOY has a significantly higher forward P/E of 38.93 [5] - ZBH's PEG ratio is 2.26, indicating a more favorable earnings growth outlook compared to ESLOY's PEG ratio of 5.06 [5] - ZBH's P/B ratio stands at 1.55, contrasting with ESLOY's P/B ratio of 3.28, suggesting ZBH is more undervalued relative to its book value [6] Investment Ratings - ZBH currently holds a Zacks Rank of 2 (Buy), indicating a stronger earnings outlook, while ESLOY has a Zacks Rank of 3 (Hold) [3] - The Value grade for ZBH is A, whereas ESLOY has a Value grade of D, further supporting the notion that ZBH is the more attractive investment option [6]